RIKI CLARK: Open Payments
NPI 1104541150 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 55 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $330 |
| Supernus Pharmaceuticals, Inc. | 5 | $182 |
| Axsome Therapeutics, Inc. | 3 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $138 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Vanda Pharmaceuticals Inc. | 3 | $113 |
| ABBVIE INC. | 5 | $95 |
| Alkermes, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
Products named: COBENFY, Qelbree, Auvelity, CAPLYTA, HETLIOZ, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
